msd
Executive Director, Global Marketing Oncology
At a Glance
- Location
- USA - New Jersey - Rahway, United States
- Work Regime
- hybrid
- Employment
- Full time
- Experience
- 12+ years
- Compensation
- salary range for this role is $255,800.00 - $402,700.00 This is the lowest to highest
- Posted
- 2026-03-31
Key Requirements
Domain Knowledge
- Clinical
- Finance
- Marketing
- Regulatory
Requirements
Accountability, Business Development, Business Development Initiatives, Clinical Development, Decision Making, Developing Pricing Strategies, Innovation, Leadership, Market Development, Market Research, Oncology Marketing, People Leadership, Product Launch Support, Relationship Building, Sales and Operations Planning (S&OP), Strategic Communication Management, Strategic Thinking, Talent Management
Pipeline/early development experience
Experience providing commercial input on such activities as:
Target product profile development, global regulatory filing strategy, launch readiness reviews, organized customer interactions, market research, demand, revenue, and P&L forecasting, BD&L activities, product development team (PDT) and agency partner management
Experience working with finance and business planning to manage brand forecast and S&OP process
Responsibilities
Our marketing team is passionate about bringing our oncology products to our customers around the world to help them drive improved patient outcomes.
We are recruiting for a Global Marketing Executive Director to lead select wave- and asset-specific planning.
This role requires outstanding leadership and deep experience in global pipeline, portfolio and product strategy, as well as brand development and launch preparedness.
It requires close coordination with relevant disease, functional and geographic counterparts, and managing and guiding a high-performing global marketing team.
As a leader on the global commercial asset team, this individual will be responsible for:
Guiding the development and evolution of select elements of the commercial asset strategy, as well as initial strategy work for certain indications, including development of indication-level L3 and other marketing strategy-related asset deliverables in close collaboration with relevant disease teams, ensuring consistency and cohesion with relevant asset and disease portfolio strategies